ITGA2 and neoplasm: Interrogation of the NK cell population revealed a significant 1.5-2-fold increase in total CD3-CD122+CD49b+ NK cells within the tumour compartment of VSVΔ51+T-DM1 treated mice compared to monotherapies or PBS controls (Figures 7J, and S5H, I) at D7.